Dexcom (DXCM) Interest Coverage Ratio Growth (3y) (2013 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.80% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.94% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -35.05% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.28% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -4.98% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 86.63% |
| Mar 31, 2023 | 67.54% |
| Dec 31, 2022 | 59.03% |
| Sep 30, 2022 | 105.25% |
| Jun 30, 2022 | 576.19% |
| Mar 31, 2022 | 124.34% |
| Dec 31, 2021 | 26.13% |
| Sep 30, 2021 | 108.51% |
| Jun 30, 2021 | 182.78% |
| Mar 31, 2021 | 52.22% |
| Dec 31, 2020 | -43.59% |
| Sep 30, 2020 | 232.35% |
| Jun 30, 2020 | 40.29% |
| Mar 31, 2020 | 26.56% |
| Dec 31, 2019 | 32.50% |
| Sep 30, 2019 | 26.83% |
| Jun 30, 2019 | 93.57% |
| Mar 31, 2019 | 82.86% |
| Sep 30, 2018 | 26.13% |
| Jun 30, 2018 | 69.51% |
| Mar 31, 2018 | 53.47% |
| Dec 31, 2017 | -31.66% |
| Sep 30, 2017 | 83.56% |
| Jun 30, 2017 | 46.72% |
| Mar 31, 2017 | -9.52% |
| Dec 31, 2016 | -38.42% |
| Sep 30, 2016 | -47.20% |
| Jun 30, 2016 | -59.54% |
| Mar 31, 2016 | -52.16% |
| Dec 31, 2014 | -81.30% |
| Sep 30, 2014 | 87.66% |
| Jun 30, 2014 | 77.25% |
| Mar 31, 2014 | 68.56% |
| Dec 31, 2013 | -26.64% |
| Sep 30, 2013 | 53.94% |
| Jun 30, 2013 | 4.70% |